We are live on
!
Find out more
BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
1-Year Est. Return
51.97%
This Fund
S&P 500
This Quarter
Est. Return
+6.85%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$109M
(+7.9%)
Cap. Flow
+$60.5M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
11.4%
Holding
548
New
180
Increased
104
Reduced
85
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$31M |
| 2 |
Alkermes
ALKS
|
+$17M |
| 3 |
Herc Holdings
HRI
|
+$16M |
| 4 |
DCH
Dauch Corp
DCH
|
+$15.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$15M |
| 2 |
Take-Two Interactive
TTWO
|
+$14.4M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$13.6M |
| 4 |
NetEase
NTES
|
+$13.1M |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.13% |
| 2 | Industrials | 16.2% |
| 3 | Healthcare | 15.95% |
| 4 | Technology | 13.15% |
| 5 | Materials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFN
201
DELISTED
Infinera Corporation Common Stock
INFN
| $1.51M | 0.1% |
+94,107
| New | +$1.44M |
|
|
IL
202
DELISTED
IntraLinks Holdings Inc.
IL
| $1.5M | 0.1% |
190,206
+168,357
| +771% | +$1.32M |
|
|
LM
203
DELISTED
Legg Mason, Inc.
LM
| $1.49M | 0.1% |
43,086
+9,116
| +27% | +$286K |
|
204
Hackett Group
HCKT
$270M
| $1.49M | 0.1% |
98,764
-23,238
| -19% | -$332K |
|
205
Caesars Entertainment
CZR
$6.06B
| $1.49M | 0.1% |
130,463
+70,142
| +116% | +$729K |
|
206
Colliers International
CIGI
$5.04B
| $1.49M | 0.1% |
39,369
+23,769
| +152% | +$874K |
|
|
EGN
207
DELISTED
Energen
EGN
| $1.48M | 0.1% |
+40,569
| New | +$1.26M |
|
208
BWX Technologies
BWXT
$15.5B
| $1.48M | 0.1% |
44,200
-2,600
| -6% | -$80.3K |
|
209
Caleres
CAL
$431M
| $1.47M | 0.1% |
+51,945
| New | +$1.38M |
|
|
ERF
210
DELISTED
Enerplus Corporation
ERF
| $1.47M | 0.1% |
373,892
| – | – |
|
211
CorVel
CRVL
$3.06B
| $1.47M | 0.1% |
+111,492
| New | +$1.57M |
|
|
AEPI
212
DELISTED
AEP Industries Inc
AEPI
| $1.46M | 0.1% |
22,135
-3,661
| -14% | -$277K |
|
|
VWR
213
DELISTED
VWR Corporation
VWR
| $1.46M | 0.1% |
53,883
-28,317
| -34% | -$700K |
|
|
AVNS
214
DELISTED
Avanos Medical
AVNS
| $1.46M | 0.1% |
+50,700
| New | +$1.35M |
|
|
AGTC
215
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.45M | 0.1% |
103,973
-26,953
| -21% | -$395K |
|
|
CNR
216
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.45M | 0.1% |
+102,252
| New | +$1.14M |
|
217
Babcock & Wilcox
BW
$1.39B
| $1.45M | 0.1% |
6,770
+5,802
| +599% | +$1.16M |
|
|
NPKI
218
NPK International
NPKI
$1.06B
| $1.45M | 0.1% |
335,165
+137,303
| +69% | +$587K |
|
|
OSG
219
Octave Specialty Group
OSG
$243M
| $1.44M | 0.1% |
91,235
-37,924
| -29% | -$549K |
|
220
Avis
CAR
$4.86B
| $1.44M | 0.1% |
52,497
+13,930
| +36% | +$381K |
|
|
FBR
221
DELISTED
Fibria Celulose Sa
FBR
| $1.43M | 0.1% |
+168,413
| New | +$1.7M |
|
222
Essent Group
ESNT
$6.08B
| $1.42M | 0.1% |
+68,507
| New | +$1.31M |
|
|
CHMT
223
DELISTED
Chemtura Corporation
CHMT
| $1.42M | 0.09% |
+53,800
| New | +$1.37M |
|
224
Crocs
CROX
$6.14B
| $1.42M | 0.09% |
+147,545
| New | +$1.37M |
|
225
Mercer International
MERC
$42.3M
| $1.42M | 0.09% |
149,776
+90,711
| +154% | +$732K |
|
Similar funds
FC
NISOA
UMA
HS
DFG
SRCM
OFM
SAM
Bogle Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, Bogle Investment Management held 548 positions worth $1.5B, up 7.9% from $1.39B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bogle Investment Management deployed $60.5M of net new capital in Q1 2016, opening 180 new positions and adding to 104 existing holdings. Its largest new stake was Bausch Health: 419,115 shares worth $11M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was New Oriental, an estimated $11M trimmed.
- Bogle Investment Management's largest Q1 2016 buy was Bausch Health: 419,115 shares worth $11M.
- Bogle Investment Management added most to Herc Holdings in Q1 2016, an estimated $16M increase.
- Bogle Investment Management's biggest Q1 2016 reduction was New Oriental, cutting an estimated $11M.
- Bogle Investment Management fully exited Manhattan Associates in Q1 2016, selling an estimated $15M.
- Bogle Investment Management's ten largest holdings make up 11% of its $1.5B portfolio in Q1 2016.
- Bogle Investment Management opened 180 new positions and closed 172 in Q1 2016.
- Bogle Investment Management's portfolio value rose 7.9% quarter-over-quarter to $1.5B.
Based on Bogle Investment Management's 13F filing for Q1 2016, filed 13 May 2016.